Myelofibrosis  >>  AZD1480  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD1480 / AstraZeneca
NCT00910728 / 2007-006647-45: Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases

Completed
1
65
US, Europe
AZD1480
AstraZeneca, University of Texas, New York City Hoffman Center, Gustave Roussy, Cancer Campus, Grand Paris
Primary Myelofibrosis (PMF), Post-Polycythaemia Vera, Essential Thrombocythaemia Myelofibrosis
03/12
08/14

Download Options